12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. CytoSorbents (CTSO), Tonix Pharmaceuticals (TNXP), TRACON Pharma (TCON), Butterfly Network (BFLY), Renalytix (RNLX), and Genprex (GNPX) experienced gains, with CTSO leading at a 17.3% increase. Conversely, Bone Biologics (BBLG) saw the largest drop of 38.5%, followed by declines in SILO Pharma (SILO), Impel Pharmaceuticals (IMPL), Aclarion (ACON), Intelligent Bio Solutions (INBS), and BioCardia (BCDA). Earnings reports released three days ago influenced some of these stock movements.
November 17, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Butterfly Network's stock rose by 12.6% to $1.25, with a market value of $258.8 million.
The upward movement in pre-market trading may continue into the regular session, reflecting investor interest.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
CytoSorbents stock rose 17.3% in pre-market trading with a market cap of $57.3 million.
The significant pre-market gain suggests positive investor sentiment, which could lead to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Genprex shares rose 11.12% to $0.26, with a market value of $15.7 million after its Q3 earnings report.
The increase after the Q3 earnings report indicates a positive investor response, potentially leading to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Renalytix stock increased by 11.66% to $0.67, with a market value of $32.6 million following its Q1 earnings release.
The positive reaction to the Q1 earnings could suggest a bullish short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
TRACON Pharma's stock saw a 14.13% increase to $0.18 with a market cap of $5.6 million.
The stock's pre-market performance could lead to a short-term positive trend, reflecting investor confidence.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tonix Pharmaceuticals stock increased by 15.43% to $0.54 with a market cap of $12.8 million.
The pre-market rise indicates a positive short-term outlook, potentially due to recent company developments or market conditions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Aclarion shares decreased by 12.52% to $0.31 following its Q3 earnings report, with a market cap of $2.5 million.
The negative movement after the Q3 earnings suggests a bearish outlook, which could continue in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
Bone Biologics stock plummeted by 38.5% to $0.48, with a market value of $1.5 million after its Q3 earnings release.
The sharp decline following the Q3 earnings suggests a negative investor reaction, likely leading to a short-term downtrend.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
NEGATIVE IMPACT
BioCardia shares declined by 10.4% to $0.72, with a market value of $15.5 million.
The stock's pre-market drop could be a sign of negative sentiment, possibly affecting its short-term price direction.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Impel Pharmaceuticals stock decreased by 13.33% to $0.31, with a market value of $7.3 million.
The drop in pre-market could reflect negative market sentiment, potentially leading to a short-term decrease in stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Intelligent Bio Solutions stock decreased by 10.56% to $0.47, with a market value of $4.0 million.
The pre-market decline may indicate a lack of investor confidence, potentially leading to a short-term negative impact on the stock.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
SILO Pharma stock fell 16.11% to $1.25, with a market value of $3.8 million.
The pre-market decline may suggest bearish sentiment that could affect the stock's short-term performance.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80